Prognostic and Therapeutic Role of Angiogenic Microenvironment in Thyroid Cancer

Prognostic and Therapeutic Role of Angiogenic Microenvironment in Thyroid Cancer

Thyroid cancer is the most common endocrine malignancy, with a typically favorable prognosis following standard treatments, such as surgical resection and radioiodine therapy. A subset of thyroid cancers progress to refractory/metastatic disease. Understanding how the tumor microenvironment is trans...

Full description

Bibliographic Details
Main Authors:	Assunta Melaccio, Lucia Ilaria Sgaramella, Alessandro Pasculli, Giovanna Di Meo, Angela Gurrado, Francesco Paolo Prete, Angelo Vacca, Roberto Ria, Mario Testini
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Cancers
Subjects:	thyroid carcinoma angiogenic microenvironment prognostic factors antiangiogenic therapy therapeutic target tumor microenvironment
Online Access:	https://www.mdpi.com/2072-6694/13/11/2775

Similar Items

Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
by: Lars M. Schiffmann, et al.
Published: (2022-05-01)

Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance
by: Assunta Melaccio, et al.
Published: (2022-11-01)

The role of angiogenic growth factors in the immune microenvironment of glioma
by: Zhengmao Ge, et al.
Published: (2023-09-01)

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
by: Changyu Yao, et al.
Published: (2023-01-01)

Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance
by: Yue Huiran, et al.
Published: (2023-04-01)

Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
by: Wuzhen Chen, et al.
Published: (2021-07-01)

Metamorphic Effect of Angiogenic Switch in Tumor Development: Conundrum of Tumor Angiogenesis Toward Progression and Metastatic Potential
by: Daniel Leon Moshe, et al.
Published: (2023-07-01)

Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
by: Christopher Montemagno, et al.
Published: (2020-07-01)

Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling
by: Alice Mougel, et al.
Published: (2022-12-01)

The E3 ubiquitin ligase RBCK1: Implications in the tumor immune microenvironment and antiangiogenic therapy of glioma
by: Jing Guo, et al.
Published: (2023-01-01)

Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives
by: Laurenz Nagl, et al.
Published: (2020-08-01)

A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients
by: Hong Chen, et al.
Published: (2023-10-01)

The immune landscape of the microenvironment of thyroid cancer is closely related to differentiation status
by: Lucas Leite Cunha, et al.
Published: (2021-07-01)

The Value of Intraoperative Ultrasound in Selective Lateral Cervical Neck Lymphadenectomy for Papillary Thyroid Cancer: A Prospective Pilot Study
by: Giovanna Di Meo, et al.
Published: (2021-05-01)

Effect of Antibiotic Prophylaxis on Surgical Site Infection in Thyroid and Parathyroid Surgery: A Systematic Review and Meta-Analysis
by: Andrea Polistena, et al.
Published: (2022-02-01)

Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma
by: Yuan Cui, et al.
Published: (2022-09-01)

Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
by: Meng Yuan, et al.
Published: (2022-11-01)

A novel prognostic predictor of immune microenvironment and therapeutic response in clear cell renal cell carcinoma based on angiogenesis–immune-related gene signature
by: Guixin Ding, et al.
Published: (2024-01-01)

Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
by: Roberto Ria, et al.
Published: (2020-06-01)

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
by: Alessandro Prete, et al.
Published: (2021-06-01)

Targeting vascular normalization: a promising strategy to improve immune–vascular crosstalk in cancer immunotherapy
by: Cheng Qian, et al.
Published: (2023-12-01)

Angiogenesis Inhibition in Prostate Cancer: An Update
by: Chandrani Sarkar, et al.
Published: (2020-08-01)

Non-Coding RNAs in Glioma Microenvironment and Angiogenesis
by: Dongxue Li, et al.
Published: (2021-11-01)

The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer
by: Nerina Denaro, et al.
Published: (2023-04-01)

A pyroptosis-related gene signature for prognosis and immune microenvironment of pancreatic cancer
by: Sifan Tao, et al.
Published: (2022-08-01)

Can low‐dose radiotherapy volumes be one of the contributing factors to early relapses in lung cancer patients?
by: Huriye Senay Kiziltan, et al.
Published: (2018-03-01)

Cell Component and Function of Tumor Microenvironment in Thyroid Cancer
by: Eunah Shin, et al.
Published: (2022-10-01)

A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients
by: Shengkai Geng, et al.
Published: (2022-08-01)

Crosstalk between Thyroid Carcinoma and Tumor-Correlated Immune Cells in the Tumor Microenvironment
by: Mingyuan Song, et al.
Published: (2023-05-01)

The Tumor Microenvironment of DLBCL in the Computational Era
by: Giuseppina Opinto, et al.
Published: (2020-03-01)

Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
by: Ali S. Arbab, et al.
Published: (2017-12-01)

Anti-Angiogenic Activity of Drugs in Multiple Myeloma
by: Ilaria Saltarella, et al.
Published: (2023-03-01)

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma
by: Yuan Qin, et al.
Published: (2022-09-01)

The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?
by: Jiayao Ma, et al.
Published: (2021-10-01)

The Prostate Cancer Immune Microenvironment, Biomarkers and Therapeutic Intervention
by: Yangyi Zhang, et al.
Published: (2022-04-01)

Histological perspective on the effects of tumor-associated macrophages in the tumor microenvironment surrounding papillary thyroid carcinoma
by: Nuray Y. Can, et al.
Published: (2017-02-01)

OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer
by: Min Mao, et al.
Published: (2021-01-01)

Maternal serum concentrations of angiogenic and antiangiogenic factors in threatened miscarriage at 7–12 weeks’ gestation and the risk of adverse pregnancy outcomes
by: Dina Gamal Eldeen Y. Elkholi, et al.
Published: (2013-09-01)

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents
by: Saumil Datar, et al.
Published: (2020-12-01)

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
by: Xianchao Sun, et al.
Published: (2021-05-01)